Firmagon 80 mg Injection is used to treat advanced prostate cancer, as it helps reduce testosterone levels, which in turn aids in cancer treatment.
Firmagon injections contain the active ingredient degarelix, a GnRH receptor antagonist that helps manage advanced prostate cancer by lowering testosterone levels.
Firmagon injections are used in the treatment of advanced prostate cancer.
Firmagon is administered by subcutaneous injection (under the skin).
Initial Firmagon dose: 240 mg given as two injections of 120 mg each.
Maintenance dose: 80 mg once every 28 days.
Firmagon may cause some side effects, including:
Pain or swelling at the injection site
Hot flashes
Weight gain
Increased liver enzyme levels
Fatigue
High blood pressure
Decreased libido
Erectile dysfunction
Firmagon injections should not be used in cases of:
Hypersensitivity to any of its components
Pregnancy
Caution is advised before using Firmagon injections, especially in patients with:
Irregular heartbeat (arrhythmia)
Congestive heart failure
Use of antiarrhythmic medications
Kidney or liver problems
Breastfeeding women
Keep out of reach of children.
Store at a temperature between 15°C and 25°C.